Critique of "adjuvant intravenous methotrexate of definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Concluding report of an RTOG randomized trial on 638 patients".
D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D006801:Humans; D007822:Laryngeal Neoplasms / Q000628:therapy*; D008727:Methotrexate / Q000008:administration & dosage*; D009062:Mouth Neoplasms / Q000628:therapy*; D010610:Pharyngeal Neoplasms / Q000628:therapy*
D008727:Methotrexate